Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00539318|
Recruitment Status : Terminated (Low Recruitment)
First Posted : October 4, 2007
Last Update Posted : August 14, 2009
The proposal seeks to establish:
- A comprehensive compilation (database) of clinical information comprising clinical, histopathological, treatment and follow-up characteristics of past and future gastrointestinal cancer (GIC) cases in Singapore that can be shared by investigators. The characteristics will include clinical (eg age, sex, stage), histopathological (eg. grade, type), treatment (eg. treatment status, regimens) and outcome data (eg. survival, toxicity) from medical records.
- A collection (bank) of corresponding frozen and fixed tissue, blood and processed samples (enriched blood mononuclear cells, protein, RNA, DNA, tissue arrays) in Singapore that can be shared by the investigators.
- A gastrointestinal cancer co-operative group (GCCG) of clinicians and scientists researching prognostic and predictive markers in GIC, which will benefit from the multidisciplinary knowledge, information and samples of its members.
|Condition or disease||Intervention/treatment|
|Gastrointestinal Cancer||Procedure: Blood drawing|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||60 participants|
|Official Title:||Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers|
|Study Start Date :||August 2007|
|Actual Study Completion Date :||July 2009|
Procedure: Blood drawing
Once when enroll in study
- there is no primary outcome measures in this study [ Time Frame: no time frame is provided ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00539318
|Johns Hopkins Singapore International Medical Centre|
|Singapore, Singapore, 308433|
|Principal Investigator:||Dr Alex Chang, MD||JHS IMC|